Dr. Singh has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Allergan, Ardea, Savient, and Novartis, and (more than $10,000) from Takeda, has received an investigator-initiated grant from Savient and Takeda, and is an executive member of an international organization, Outcome Measures in Rheumatology (OMERACT).
Version of Record online: 2 APR 2012
Copyright © 2012 by the American College of Rheumatology
Arthritis Care & Research
Volume 64, Issue 5, pages 625–639, May 2012
How to Cite
Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M., Moreland, L. W., O'Dell, J., Winthrop, K. L., Beukelman, T., Bridges, S. L., Chatham, W. W., Paulus, H. E., Suarez-almazor, M., Bombardier, C., Dougados, M., Khanna, D., King, C. M., Leong, A. L., Matteson, E. L., Schousboe, J. T., Moynihan, E., Kolba, K. S., Jain, A., Volkmann, E. R., Agrawal, H., Bae, S., Mudano, A. S., Patkar, N. M. and Saag, K. G. (2012), 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res, 64: 625–639. doi: 10.1002/acr.21641
The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.
Members of the Task Force Panel: Claire Bombardier, MD, MSc (University of Toronto, Toronto, Ontario, Canada), Arthur F. Kavanaugh, MD (University of California, San Diego), Dinesh Khanna, MD, MSc (University of Michigan, Ann Arbor), Joel M. Kremer, MD (Albany Medical Center, Albany, NY), Amye L. Leong, MBA (Healthy Motivation, Santa Barbara, CA), Eric L. Matteson, MD, MPH (Mayo Clinic, Rochester, MN), John T. Schousboe, MD, PhD (Park Nicollet Clinic and University of Minnesota, Minneapolis), Charles M. King, MD (North Mississippi Medical Center, Tupelo), Maxime Dougados, MD (Hôpital Cochin, Paris, France), Eileen Moynihan, MD (Highmark Medicare Services, Woodbury, NJ), Karen S. Kolba, MD (Pacific Arthritis Center, Santa Maria, CA).
Members of the Core Expert Panel: Timothy Beukelman, MD, MSCE, S. Louis Bridges Jr., MD, PhD, W. Winn Chatham, MD, Jeffrey R. Curtis, MD, MPH, Kenneth G. Saag, MD, MSc, Jasvinder A. Singh, MBBS, MPH (University of Alabama at Birmingham), Daniel E. Furst, MD, Harold E. Paulus, MD (University of California, Los Angeles), Ted Mikuls, MD, MSPH (participated in meetings only prior to June 2010; University of Nebraska, Omaha), Larry W. Moreland, MD (University of Pittsburgh, Pittsburgh, PA), James O'Dell, MD (University of Nebraska, Omaha), Maria Suarez-Almazor, MD, MPH (MD Anderson Cancer Center, Houston, TX).
Content-Specific Expert Advisors: Kevin L. Winthrop, MD, MPH (tuberculosis; Oregon Health and Science University, Portland), Michael Saag, MD (infections; University of Alabama at Birmingham).
- Issue online: 2 APR 2012
- Version of Record online: 2 APR 2012
- Manuscript Accepted: 8 FEB 2012
- Manuscript Received: 27 MAY 2011
- American College of Rheumatology
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.